Three New Color Food Additives From Natural Sources Approved by FDA
By Stephanie Brown HealthDay Reporter
FRIDAY, May 9, 2025 -- The U.S. Food and Drug Administration announced the approval of three new color additives, a move that will provide manufacturers with a wider range of color options from natural sources that can be safely used in food.
The approvals align with the U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr.'s priority of phasing out petroleum-based dyes in the national food supply.
Last month's announcement from the HHS and FDA regarding the discontinuation of petroleum-based food dyes has led to an increased commitment from U.S. food manufacturers. They have pledged to remove these dyes by the FDA deadline of the end of 2026.
The following three color additives have been approved: Galdieria extract blue, derived from the unicellular red algae Galdieria sulphuraria, and approved for use in nonalcoholic beverages and beverage bases, cereals, candies, ice creams, yogurts, and creamers; butterfly pea flower extract, produced through the water extraction of the dried flower petals of the butterfly pea plant, and approved for use in a variety of alcoholic and nonalcoholic beverages, candies, ice creams, and snacks such as crackers, chips, and pretzels; and calcium phosphate, approved for use in ready-to-eat chicken products, candies, and doughnuts.
"On April 22, I said the FDA would soon approve several new color additives and would accelerate our review of others. I'm pleased to report that promises made have been promises kept," FDA Commissioner Martin A. Makary, M.D., M.P.H., said in a statement. "FDA staff have been moving quickly to expedite the publication of these decisions, underscoring our serious intent to transition away from petroleum-based dyes in the food supply and provide new colors from natural sources."
The approvals of Galdieria extract blue, butterfly pea flower extract, and calcium phosphate were granted to French company Fermentalg, St. Louis-based Sensient Colors, and Innophos of Cranbury, New Jersey, respectively.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma
WEDNESDAY, June 25, 2025 -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large...
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes
WEDNESDAY, June 25, 2025 -- The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early...
Paternal Mental Distress Linked to Poorer Offspring Development
WEDNESDAY, June 25, 2025 -- Paternal mental distress is associated with poorer child development, according to a study published online June 16 in JAMA Pediatrics. Genevieve Le...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.